Frontiers in Immunology | Vaccines and Molecular Therapeutics

Review

Published on 15 May 2023

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

in Vaccines and Molecular Therapeutics

Susanna Esposito
Gayatri Amirthalingam
Matteo Bassetti
Francesco Blasi
Francesco Giuseppe De Rosa
Natasha B. Halasa
Ivan Hung
Albert Osterhaus
Tina Tan
Juan Pablo Torres

Frontiers in Immunology

doi 10.3389/fimmu.2023.1162342

14,357 views
24 citations

Original Research

Published on 15 May 2023

Adenoviral-vectored epigraph vaccine elicits robust, durable, and protective immunity against H3 influenza A virus in swine

in Vaccines and Molecular Therapeutics

Erika Petro-Turnquist
Matthew Pekarek
Nicholas Jeanjaquet
Cedric Wooledge
David Steffen
Hiep Vu
Eric A. Weaver

Frontiers in Immunology

doi 10.3389/fimmu.2023.1143451

7,821 views
11 citations

Review

Published on 12 May 2023

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective

in Vaccines and Molecular Therapeutics

Narges Ebrahimi
Zahra Yousefi
Gholamreza Khosravi
Fatemeh Eskandari Malayeri
Marjan Golabi
Monireh Askarzadeh
Mohammad Hossein Shams
Behrooz Ghezelbash
Nahid Eskandari

Frontiers in Immunology

doi 10.3389/fimmu.2023.1150238

22,220 views
79 citations

Original Research

Published on 12 May 2023

Biomarkers detected in cord blood predict vaccine responses in young infants

in Vaccines and Molecular Therapeutics

Carolyn H. Baloh
Guglielmo M. Venturi
Bernard M. Fischer
Liane S. Sadder
Julie J. Kim-Chang
Cliburn Chan
Kristina De Paris
Li Yin
Grace M. Aldrovandi
Maureen M. Goodenow

Frontiers in Immunology

doi 10.3389/fimmu.2023.1152538

3,973 views
6 citations

Brief Research Report

Published on 12 May 2023

Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

in Vaccines and Molecular Therapeutics

Hoi Man Ng
Chon Lok Lei
Siyi Fu
Enqin Li
Sek In Leong
Chu Iong Nip
Nga Man Choi
Kai Seng Lai
Xi Jun Tang
Chon Leng Lei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1131985

2,713 views
5 citations

Original Research

Published on 12 May 2023

Serum albumin binding knob domains engineered within a VH framework III bispecific antibody format and as chimeric peptides

in Vaccines and Molecular Therapeutics

Ralph Adams
Callum Joyce
Mikhail Kuravskiy
Katriona Harrison
Zainab Ahdash
Matthew Balmforth
Kelda Chia
Cinzia Marceddu
Matthew Coates
James Snowden

Frontiers in Immunology

doi 10.3389/fimmu.2023.1170357

9,662 views
13 citations

Perspective

Published on 12 May 2023

Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development

in Vaccines and Molecular Therapeutics

Zuben E. Sauna
Vibha Jawa
Sathy Balu-Iyer
Narendra Chirmule

Frontiers in Immunology

doi 10.3389/fimmu.2023.1151888

6,067 views
13 citations

Original Research

Published on 12 May 2023

A novel precision-serology assay for SARS-CoV-2 infection based on linear B-cell epitopes of Spike protein

in Vaccines and Molecular Therapeutics

Samuel B. Lundin
Hanna Kann
Alma Fulurija
Björn Andersson
Sravya S. Nakka
Lars-Magnus Andersson
Magnus Gisslén
Ali M. Harandi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1166924

2,691 views
2 citations

Review

Published on 10 May 2023

New tools for immunologists: models of lymph node function from cells to tissues

in Vaccines and Molecular Therapeutics

Tochukwu Ozulumba
Alyssa N. Montalbine
Jennifer E. Ortiz-Cárdenas
Rebecca R. Pompano

Frontiers in Immunology

doi 10.3389/fimmu.2023.1183286

16,698 views
27 citations

Editorial

Published on 05 May 2023

Editorial: Non-reactogenic vaccines against Q-fever

in Vaccines and Molecular Therapeutics

Anthony E. Gregory
D. Huw Davies

Frontiers in Immunology

doi 10.3389/fimmu.2023.1196522

2,471 views

Original Research

Published on 05 May 2023

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals

in Vaccines and Molecular Therapeutics

Joana Barros-Martins
Swantje I. Hammerschmidt
Gema Morillas Ramos
Anne Cossmann
Laura Hetzel
Ivan Odak
Miriam Köhler
Metodi V. Stankov
Christiane Ritter
Michaela Friedrichsen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1166589

3,962 views
10 citations

Original Research

Published on 05 May 2023

A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts

in Vaccines and Molecular Therapeutics

Peter Lorenz
Felix Steinbeck
Franz Mai
Emil C. Reisinger
Brigitte Müller-Hilke

Frontiers in Immunology

doi 10.3389/fimmu.2023.1192395

3,316 views
2 citations

Original Research

Published on 03 May 2023

Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

in Vaccines and Molecular Therapeutics

Yanan Tong
Guoxiu Lu
Zhiguo Wang
Shanhu Hao
Guoxu Zhang
Hongwu Sun

Frontiers in Immunology

doi 10.3389/fimmu.2023.1154818

3,853 views
10 citations

Original Research

Published on 02 May 2023

A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice

in Vaccines and Molecular Therapeutics

Andrew G. Diamos
Mary D. Pardhe
Melissa H. Bergeman
Aigerim S. Kamzina
Michelle P. DiPalma
Sara Aman
Artemio Chaves
Kenneth Lowe
Jacquelyn Kilbourne
Ian B. Hogue

Frontiers in Immunology

doi 10.3389/fimmu.2023.1085911

4,513 views
1 citation

Original Research

Published on 01 May 2023

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice

in Vaccines and Molecular Therapeutics

Fernando Silveira
Mariana Rivera-Patron
Nikita Deshpande
Soledad Sienra
Jackeline Checa
María Moreno
Jose A. Chabalgoity
Samuel P. Cibulski
Mariana Baz

Frontiers in Immunology

doi 10.3389/fimmu.2023.1163858

8,826 views
6 citations

Brief Research Report

Published on 28 Apr 2023

Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants

in Vaccines and Molecular Therapeutics

Dilip R. Patil
Anita M. Shete
Pragya D. Yadav
Gajanan N. Sapkal
Gururaj R. Deshpande
Himanshu Kaushal
Sreelekshmy Mohandas
Siddharam Fulari
Rajlaxmi Jain
Ajay Kumar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1161571

2,729 views
1 citation